C.H. Robinson Worldwide, Inc. (CHRW) is a publicly traded Industrials sector company. As of May 20, 2026, CHRW trades at $180.16 with a market cap of $20.01B and a P/E ratio of 36.42. CHRW moved +4.44% today. Year to date, CHRW is +5.68%; over the trailing twelve months it is +72.88%. Its 52-week range spans $84.68 to $203.34. Analyst consensus is buy with an average price target of $198.00. Rallies surfaces CHRW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading CHRW stock inside the company?
Recent CHRW insider activity includes Castagnetto Michael D. bought 594.388, Bozeman David P bought 1.22K, RAJAN ARUN bought 605, Lee Damon J. bought 620, and Freeman Angela K. sold 8.58K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
CHRW Key Metrics
Key financial metrics for CHRW
Metric
Value
Price
$180.16
Market Cap
$20.01B
P/E Ratio
36.42
EPS
$4.99
Dividend Yield
0.63%
52-Week High
$203.34
52-Week Low
$84.68
Volume
2.92M
Avg Volume
0
Revenue (TTM)
$16.20B
Net Income
$599.01M
Gross Margin
0.00%
Recent CHRW Insider Trades
Castagnetto Michael D. bought 594.388 (~$100.00K) on Feb 12, 2026.
Bozeman David P bought 1.22K (~$199.77K) on Feb 12, 2026.
RAJAN ARUN bought 605 (~$101.10K) on Feb 12, 2026.
Lee Damon J. bought 620 (~$100.76K) on Feb 12, 2026.
Freeman Angela K. sold 8.58K (~$1.72M) on Feb 9, 2026.
Recent CHRW insider activity includes Castagnetto Michael D. bought 594.388, Bozeman David P bought 1.22K, RAJAN ARUN bought 605, Lee Damon J. bought 620, and Freeman Angela K. sold 8.58K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CHRW?
Yes. Rallies tracks CHRW insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CHRW research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CHRW. It does not provide personalized investment advice.